|
Hi,
In addition to the information I sent in reply to your message, it is usual to monitor other haematological and biochemical indicators when a person starts to take carbamazepine, in case there are any adverse effects. This monitoring may be monthly to start with, becoming less frequent in older patients.
Because of the reasons already mentioned, haemolysis, small sample size, contamination with tissue fluid etcetera, these measurements would be unreliable if estimated on a heel-prick. The errors introduced could also make the carbamazepine results inaccurate.
I hope your daughter responds well to her treatment and I wish you both well.
Steve.
|